Molecular Docking of Anti Helicobacter pylori Antibiotics and Proton Pump Inhibitor: A Single Center Survey

Helicobacter pylorus (H. pylori) is a deadly bacterium responsible for significant worldwide Gastric Cancer (GC) related mortality. The present study aimed to screen all the anti-microbial drugs used to eradicate H .pylori infection and to identify the most efficient drug by using computational meth...

Full description

Bibliographic Details
Main Authors: Kanishka Uthansingh, Ratna Kumari, Girish Kumar Pati, Manas Kumar Behera, Mahesh Chandra Sahu, Jimmy Narayan, Swarup Kumar Patnaik, Pradeep Mallick, Manoj Kumar Sahu
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2021-12-01
Series:Journal of Pure and Applied Microbiology
Subjects:
Online Access:https://microbiologyjournal.org/molecular-docking-of-anti-helicobacter-pylori-antibiotics-and-proton-pump-inhibitor-a-single-center-survey/
_version_ 1818701343188058112
author Kanishka Uthansingh
Ratna Kumari
Girish Kumar Pati
Manas Kumar Behera
Mahesh Chandra Sahu
Jimmy Narayan
Swarup Kumar Patnaik
Pradeep Mallick
Manoj Kumar Sahu
author_facet Kanishka Uthansingh
Ratna Kumari
Girish Kumar Pati
Manas Kumar Behera
Mahesh Chandra Sahu
Jimmy Narayan
Swarup Kumar Patnaik
Pradeep Mallick
Manoj Kumar Sahu
author_sort Kanishka Uthansingh
collection DOAJ
description Helicobacter pylorus (H. pylori) is a deadly bacterium responsible for significant worldwide Gastric Cancer (GC) related mortality. The present study aimed to screen all the anti-microbial drugs used to eradicate H .pylori infection and to identify the most efficient drug by using computational methods through molecular docking analysis. The 3-D structure of protein chorismate synthase of H. pylori was downloaded from the Protein data bank (PDB) online browser. The x-ray crystallography structures of 13 common drugs used against H.pylori infection were also downloaded from the drug bank. We screened all 13 common drugs through molecular docking to know the most efficient binding interaction between the diverse ligand-protein complexes. The results were further compared with clinical survey data from the patients with diverse gastrointestinal H. pylori infected cases. Among the screened compounds, by in-silico approach we found that fluoroquinolone (FLRQ) and tetracycline (TET) manifested more significant interactions with chorismate synthase (CS) protein along with binding energies of -9.2 and -8.1 kcal/mole respectively. Further, the drugs were also corroborated with the survey data from patients with varied gastrointestinal disorders in our study. With this computational study, we could find FLRQ and TET may be the most efficient drug for H. pylori treatment, which can be tried in case of anti H. Pylori treatment failure due to resistance. Hence, effective inter-analysis between the experimental and computational approaches is crucial to build up a strong inhibitor.
first_indexed 2024-12-17T15:19:20Z
format Article
id doaj.art-322caedf53974b4e890ffafbc94bec55
institution Directory Open Access Journal
issn 0973-7510
2581-690X
language English
last_indexed 2024-12-17T15:19:20Z
publishDate 2021-12-01
publisher Journal of Pure and Applied Microbiology
record_format Article
series Journal of Pure and Applied Microbiology
spelling doaj.art-322caedf53974b4e890ffafbc94bec552022-12-21T21:43:26ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2021-12-011542103211610.22207/JPAM.15.4.33Molecular Docking of Anti Helicobacter pylori Antibiotics and Proton Pump Inhibitor: A Single Center SurveyKanishka Uthansinghhttps://orcid.org/0000-0002-2465-0839Ratna Kumarihttps://orcid.org/0000-0003-0317-2601Girish Kumar Patihttps://orcid.org/0000-0002-9389-1425Manas Kumar Beherahttps://orcid.org/0000-0001-6837-1893Mahesh Chandra Sahuhttps://orcid.org/0000-0003-3736-2294Jimmy Narayanhttps://orcid.org/0000-0002-8451-1558Swarup Kumar Patnaikhttps://orcid.org/0000-0002-2099-2823Pradeep Mallickhttps://orcid.org/0000-0001-5707-325XManoj Kumar Sahuhttps://orcid.org/0000-0002-2615-1726Helicobacter pylorus (H. pylori) is a deadly bacterium responsible for significant worldwide Gastric Cancer (GC) related mortality. The present study aimed to screen all the anti-microbial drugs used to eradicate H .pylori infection and to identify the most efficient drug by using computational methods through molecular docking analysis. The 3-D structure of protein chorismate synthase of H. pylori was downloaded from the Protein data bank (PDB) online browser. The x-ray crystallography structures of 13 common drugs used against H.pylori infection were also downloaded from the drug bank. We screened all 13 common drugs through molecular docking to know the most efficient binding interaction between the diverse ligand-protein complexes. The results were further compared with clinical survey data from the patients with diverse gastrointestinal H. pylori infected cases. Among the screened compounds, by in-silico approach we found that fluoroquinolone (FLRQ) and tetracycline (TET) manifested more significant interactions with chorismate synthase (CS) protein along with binding energies of -9.2 and -8.1 kcal/mole respectively. Further, the drugs were also corroborated with the survey data from patients with varied gastrointestinal disorders in our study. With this computational study, we could find FLRQ and TET may be the most efficient drug for H. pylori treatment, which can be tried in case of anti H. Pylori treatment failure due to resistance. Hence, effective inter-analysis between the experimental and computational approaches is crucial to build up a strong inhibitor.https://microbiologyjournal.org/molecular-docking-of-anti-helicobacter-pylori-antibiotics-and-proton-pump-inhibitor-a-single-center-survey/antibioticsauto-dockchorismate synthase (cs)helicobacter pylori (h. pylori)
spellingShingle Kanishka Uthansingh
Ratna Kumari
Girish Kumar Pati
Manas Kumar Behera
Mahesh Chandra Sahu
Jimmy Narayan
Swarup Kumar Patnaik
Pradeep Mallick
Manoj Kumar Sahu
Molecular Docking of Anti Helicobacter pylori Antibiotics and Proton Pump Inhibitor: A Single Center Survey
Journal of Pure and Applied Microbiology
antibiotics
auto-dock
chorismate synthase (cs)
helicobacter pylori (h. pylori)
title Molecular Docking of Anti Helicobacter pylori Antibiotics and Proton Pump Inhibitor: A Single Center Survey
title_full Molecular Docking of Anti Helicobacter pylori Antibiotics and Proton Pump Inhibitor: A Single Center Survey
title_fullStr Molecular Docking of Anti Helicobacter pylori Antibiotics and Proton Pump Inhibitor: A Single Center Survey
title_full_unstemmed Molecular Docking of Anti Helicobacter pylori Antibiotics and Proton Pump Inhibitor: A Single Center Survey
title_short Molecular Docking of Anti Helicobacter pylori Antibiotics and Proton Pump Inhibitor: A Single Center Survey
title_sort molecular docking of anti helicobacter pylori antibiotics and proton pump inhibitor a single center survey
topic antibiotics
auto-dock
chorismate synthase (cs)
helicobacter pylori (h. pylori)
url https://microbiologyjournal.org/molecular-docking-of-anti-helicobacter-pylori-antibiotics-and-proton-pump-inhibitor-a-single-center-survey/
work_keys_str_mv AT kanishkauthansingh moleculardockingofantihelicobacterpyloriantibioticsandprotonpumpinhibitorasinglecentersurvey
AT ratnakumari moleculardockingofantihelicobacterpyloriantibioticsandprotonpumpinhibitorasinglecentersurvey
AT girishkumarpati moleculardockingofantihelicobacterpyloriantibioticsandprotonpumpinhibitorasinglecentersurvey
AT manaskumarbehera moleculardockingofantihelicobacterpyloriantibioticsandprotonpumpinhibitorasinglecentersurvey
AT maheshchandrasahu moleculardockingofantihelicobacterpyloriantibioticsandprotonpumpinhibitorasinglecentersurvey
AT jimmynarayan moleculardockingofantihelicobacterpyloriantibioticsandprotonpumpinhibitorasinglecentersurvey
AT swarupkumarpatnaik moleculardockingofantihelicobacterpyloriantibioticsandprotonpumpinhibitorasinglecentersurvey
AT pradeepmallick moleculardockingofantihelicobacterpyloriantibioticsandprotonpumpinhibitorasinglecentersurvey
AT manojkumarsahu moleculardockingofantihelicobacterpyloriantibioticsandprotonpumpinhibitorasinglecentersurvey